Vapotherm Reports Second Quarter 2024 Financial Results
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 12 2024
0mins
Source: PRnewswire
Financial Performance: Vapotherm, Inc. reported a 5.3% increase in net revenue for Q2 2024, totaling $16.9 million, driven by a significant rise in U.S. disposables revenue, which grew by 25.9% compared to the previous year. The company's gross margin improved to 49.1%, and its adjusted EBITDA loss decreased from $6.4 million in Q2 2023 to $2.9 million in Q2 2024.
Operational Highlights: The company noted increased adoption of its respiratory technology among COPD patients following positive study results presented at a recent congress. However, it faced challenges with international revenue, which declined by 15% due to reduced disposables sales in distributor markets.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
